Scientific Advisory Council

Laurie H. Glimcher, MD

Dana-Farber Cancer Institute

Boston, MA

Dr. Laurie H. Glimcher is the president and chief executive officer of the Dana-Farber Cancer Institute, and also serves on the National Cancer Moonshot Blue Ribbon Panel.

Dr. Glimcher first achieved renown for her discoveries involving the differentiation of T cells, especially CD4+ T cells, which earned her the 2012 William B. Coley Award for Distinguished Research in Basic Immunology, the L’Oréal-UNESCO Award for Women in Science, and election to the National Academy of Sciences, among other honors.

Dr. Glimcher has been a member of CRI’s Scientific Advisory Council since 2006.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.